Naresh Jain

Naresh Jain

Company: NJ Biopharmaceuticals

Job title: Chief Executive Officer


Protoxins: The Next Generation of Toxins for Antibody-Drug Conjugates 10:30 am

Examining reversible and non-reversible Protoxins Reviewing Protoxins of PBD dimers, maytansine, and MMAE Demonstrating improved stability of Protoxin-ADCsRead more

day: day 2- am

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.